SCNX Scienture Holdings, Inc.

NASDAQ
$2.44

Scienture Holdings, Inc. (SCNX) is expected to report earnings on February 12, 2027, before the market open. The consensus earnings estimate is a loss of $0.37 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -13.0% since its last earnings release on November 13, 2026.

Scienture Missed Consensus Estimates
Monday, November 16, 2026 · 8:30 AM ET
Earnings Date
4th Quarter, Dec 2026
Feb 12
Friday · 8:10 AM ET
Earnings Whisper
-
vs ($0.37)
Rev est $2.81M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $2.77

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Scienture Holdings, Inc.

Scienture Holdings Inc., through its wholly owned subsidiaries, Scienture and Integra Pharma Solutions, LLC, is a comprehensive pharmaceutical product company focused on providing enhanced value to patients, physicians and caregivers by offering novel specialty products to satisfy unmet market needs. Scienture Holdings Inc., formerly known as TRxADE Health Inc., is based in TAMPA, FL.

Charts powered in part by Lightweight Charts™ by TradingView.